Zota Health Care growth ratios

·UnclassifiedChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+83.9%+62.3%+29.0%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+423.4%−175.9%+3.0%
−30.6%−290.5%−171.1%
−30.6%−295.5%−148.5%
−8.6%−269.9%−144.1%
+157.6%+92.3%+44.4%
+206.5%+152.5%+12.0%
−69.0%−734.9%−198.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZOTA₹1,323.60

Zota Health Care LImited

· Unclassified
₹ CrorePeersMARINEBETATHEJOMcap ₹4,584 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—+29.0+62.3+83.9—
EBITDA Growth—+3.0-175.9+423.4—
EBIT Growth—-171.1-290.5-30.6—
Net Income Growth—-148.5-295.5-30.6—
EPS Growth—-144.1-269.9-8.6—
Total Assets Growth—+44.4+92.3+157.6—
Total Equity Growth—+12.0+152.5+206.5—
Cash from Operations Growth—-198.3-734.9-69.0—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.